在BAIAP2中De novo误解变异与发育性和性脑病变有关
Gang Zhang1, Yaping Lu2, Lingling Xie3
1Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Epilepsia
|October 24, 2025
概括
BAIAP2中的新遗传变异会导致发育性和性脑病变 (DEE). 这些BAIAP2基因突变破坏了大脑发育,并增加了受影响儿童的活动.
科学领域:
- 神经遗传学 神经遗传学
- 发育神经科学的发展神经科学.
- 的研究研究.
背景情况:
- 脑特异性血管生成抑制剂1-关联蛋白2 (BAIAP2) 对于树突性脊柱形成和突触发育至关重要.
- 发育性和性脑病变 (DEE) 是一种严重的神经疾病,其特征是耐火性和发育迟缓.
研究的目的:
- 为了确定DEE的新型遗传原因.
- 调查 BAIAP2 基因中 de novo 变异在 DEEs 病变发生过程中的作用.
主要方法:
- 在6名DEE患者的整体外基因组/基因组测序中,在BAIAP2.2中发现了新的误解变异.
- 使用in silico分子对接和功能测试 (细胞培养,初级神经元,斑马鱼) 来评估这些变体的影响.
主要成果:
- 所有六名患者都出现了严重的早期,发育迟缓和智力障碍.
- 变种聚集在关键的酸化区域,破坏BAIAP2的自身抑制状态并促进异常细胞突起.
- 具有BAIAP2变异的神经元表现出增加的兴奋性和增强的激发性突触生成;斑马鱼模型表现出发育缺陷和增加的敏感性.
结论:
- 在BAIAP2中出现的de novo变异是最近发现的DEE的原因之一.
- 在BAIAP2中获得功能突变会破坏细胞过程,导致和发育障碍.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
814
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Point and Frameshift Mutations
835
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
835
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Alternative RNA Splicing
24.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.7K


